zecs, just looked at the trial results again, I think the title of the trial is very interesting.
A phase I/II trial of NOX66 in combination with nivolumab in patients (pts) with advanced cancer.
Treating patients with ADVANCED CANCERS which means if i understanding this correctly patients who may be in palliative care or close to it, and most likely stage 4 metastatic cancers.
So as far as i am concerned to getting the results we got in MY OPINION is very significant.
let's see the details next week.
zecs, just looked at the trial results again, I think the title...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.37M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 8.0¢ | 7.9¢ | $1.203K | 15.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79733 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 151642 | 2 |
View Market Depth
| Last trade - 11.45am 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.000 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 7.9¢ | 7.9¢ | 2000 | ||
| Last updated 14.36pm 31/05/2024 ? | |||||
| NOX (ASX) Chart |